Study reports final clinical trial data for advanced kidney cancer treatment

The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.

Turn left for the plan, turn right for the miracle: When triplets couldn’t wait for Nashville

Triplets decided to enter the world at 26 weeks. The plan was Nashville, but it was a left turn and an hour away. Would choosing the local hospital be right?

Celebrating its 10th anniversary, the Vanderbilt Music Cognition Lab is a space for learning for everyone involved 

Researchers at Vanderbilt University Medical Center are on their way to finding out what science has to say about why music is important for health.

A fast daily walk could extend your life: study

Just 15 minutes per day of fast walking reduced the risk of premature death in a low-income and predominantly Black U.S. population.

Large-scale study uncovers 57 genetic hotspots into stuttering origins

The video is produced by the research team to explain the results of the study. Findings from the largest genetic analysis of stuttering are published in Nature Genetics; they point to 48 genes associated with stuttering and highlight neurological pathways of risk.

Mount Sinai Health System achieves 94% response rate in professional accountability program through partnership with Vanderbilt Health’s CPPA